ANGAS, NCT06091436: To Investigate Efficacy and Safety of a Single Injection of GenSci094 for Ovarian Stimulation Using Daily Recombinant FSH as Reference |
|
|
| Completed | 3 | 176 | RoW | GenSci094, Placebo RecFSH / follitropin alfa, Biological: RecFSH / Follitropin alfa (Days 1 to 7), Placebo GenSci094, RecFSH / Follitropin alfa (Days 8 to hCG), Ganirelix, hCG, Progesterone | Changchun GeneScience Pharmaceutical Co., Ltd., Sixth Affiliated Hospital, Sun Yat-sen University | Infertility | 12/23 | 01/24 | | |
NCT05738382: Efficacy and Safety of BG2109 During Controlled Ovarian Hyperstimulation in Female Subjects Undergoing ART Procedures |
|
|
| Not yet recruiting | 2 | 240 | RoW | BG2109, Cetrorelix, Cetrorelix Acetate | Bio Genuine (Shanghai) Biotech Co., Ltd. | Assisted Reproductive Technology, Controlled Ovarian Hyperstimulation | 06/24 | 12/24 | | |
NCT06321107: Long-term Follow-up Safety of a Single Injection of GenSci094 for Ovarian Stimulation Using Daily Recombinant FSH as Reference |
|
|
| Recruiting | N/A | 158 | RoW | | Changchun GeneScience Pharmaceutical Co., Ltd., Sixth Affiliated Hospital, Sun Yat-sen University | Infertility | 08/25 | 10/25 | | |
